Within this trial 15 mg (or 10 mg if GFR ≤50 ml) of solitary rivaroxaban was compared to rivaroxaban and concomitant aspirin (or P2Y12 inhibitor) in individuals with stable CAD and AF in an Asian population. This evidence concerns the gene P2RY12 and atrial fibrillation.